Tri-mix Papaverine 18 recalls

The FDA has published 2 recalls involving Tri-mix Papaverine 18 since 2021. The latest was reported on 17 Nov 2021. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2021

Last 12 months0reported

Class I00% of total

Ongoing0latest 17 Nov 2021

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why tri-mix papaverine 18 is recalled

Sterility2100%

Companies

Vita Pharmacy2100%

By year

20212100%

All tri-mix papaverine 18 recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
17 Nov 2021Drug	CLASS II	Tri-mix Papaverine 18/phentol 0.6/pge-1 Inj Injectable recalled	Vita Pharmacy	Sterility	DC, PR
17 Nov 2021Drug	CLASS II	Tri-mix Papaverine 18/phentol 0.6/pge-1 Inj Injectable recalled	Vita Pharmacy	Sterility	DC, PR

Should you stop taking Tri-mix Papaverine 18?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.